Executive Profile

Henri A. Termeer Chairman, Chief Executive Officer and President, Genzyme Oncology, Inc.

Age	Total Calculated Compensation	This person is connected to 14 Board Members in 14 different organizations across 18 different industries. See Board Relationships
66	--

Background

Mr. Henri A. Termeer has been Chief Executive Officer of Sanofi Biosurgery since December 1985 and has been its Chairman and President since May 1988 and October 1983. Mr. Termeer served as Chief Executive Officer and President of Genzyme Tissue Repair and Genzyme General since December 1985 and October 1983 respectively. Mr. Termeer served at Genzyme Surgical Products and rEVO Biologics. He served as the Chief Executive Officer of Genzyme Oncology Inc. and Genzyme Corporation ... from May 1988 to April 2011 and from December 1985 to April 2011 respectively. Mr. Termeer served as President of Genzyme Oncology Inc. since October 1983 and its Chairman of the Board of Directors since May 1988. He served as President of Genzyme Sanofi since October 1983 and its Chief Executive Officer since December 1985 and Chairman of the Board of Directors since May 1988. Mr. Termeer served as the Chairman of the Board of Genzyme Tissue Repair and Genzyme General since May 1988 and served as Chief Executive Officer since December 1985 and President since October 1983. He held various management positions over a 10-year period at Baxter Travenol Laboratories Inc. (now Baxter International), including Executive Vice President of Baxter's Hyland Therapeutics Division and General Manager of Travenol GmbH in Germany. Mr. Termeer served GTC Biotherapeutics, Inc. from 1993 to 2002. He served as the President of Genzyme Corporation from October 1983 to April 2011 and served as its Executive Chairman since May 1988. He has been Chairman of Federal Reserve Bank Of Boston Inc. since September 2009. Mr. Termeer serves as the Chairman of Federal Reserve Bank of Kansas City for Federal Reserve Bank of Atlanta. He serves as Co-Chairman of the Leadership Council of the Massachusetts Life Sciences Collaborative. He serves as the Chairman of the Harvard Medical School Genetics Advisory Council. He serves as Chairman emeritus of the New England Healthcare Institute. Mr. Termeer serves as Chairman of Medical Simulation Corporation. He has been Chairman of Federal Reserve Bank Of Boston Inc. since September 2009 and has been its Director since 2007. He served as Chairman of Genzyme Tissue Repair since May 1988 and served as its Director since 1983. Since 2002, he served as Chairman of the New England Healthcare Institute (NEHI). He serves as Vice-Chairman of the Boston Museum of Science. He served as Vice Chairman of Federal Reserve Bank Of Boston Inc. from 2007 to September 2009. He served as Vice Chairman of Federal Reserve Bank of Boston Inc. from 2007 to September 2009. He serves as a Trustee for Darden Graduate School of Business Administration. He serves as a Director of the Biomedical Science Careers Program, and a Board Member of the Massachusetts High Technology Council. Mr. Termeer has been a Director of Lotus Development Corp. since 1993. He has been a Director of Abiomed Inc. since 1987. Mr. Termeer has been Director of Abiomed Europe GmbH since 1987 and Genzyme Corporation since October 1983. Mr. Termeer serves as a Director of Federal Reserve Bank of Kansas City for Federal Reserve Bank of Atlanta. Mr. Termeer has been a Trustee of Hambrecht & Quist Life Sciences Investors Fund since 1989. Mr. Termeer has been a Director of Verastem, Inc. since June 2011 and also serves as its Lead Director. He has been a Director of AVEO Pharmaceuticals, Inc. since April 2011. Mr. Termeer serves as a Director of Partners HealthCare System, Inc., IG Laboratories Inc., Xenova Corp., and Neozyme II Corp. He serves as a Director of Biotechnology Industry Organization (BIO), Pharmaceutical Research and Manufacturers of America (PhRMA). Mr. Termeer has been a Director of Federal Reserve Bank of Boston Inc. since 2007 and Moderna Therapeutics, Inc. since April 30, 2013. He serves on the Board of Associates of the Whitehead Institute and on the Board of Trustees of Massachusetts General Hospital. He serves as a Director of Massachusetts General Hospital. He serves as Member of the Board of Directors of Project HOPE. Since 2008, he served as Massachusetts Governor Deval Patrick's Council of Economic Advisors. He served as a Trustee of H&Q Healthcare Investors since 1989 and HQL fund since 1992. Mr. Termeer served as a Director of Genzyme Biosurgery Corporation since October 1983. He served as a Director of Biotechnology Industry Organization. Mr. Termeer served as Director of Genzyme Tissue Repair, Genzyme Oncology Inc. and Genzyme General since October 1983. He served as a Trustee of H&Q Life Sciences Investors Fund from 1992 to June 21, 2007. Mr. Termeer served as an Independent Trustee of Hql Fund and H&Q Healthcare Investor Fund since 1992 and 1989 respectively. He served as a Director of Diacrin Inc. from 1996 to 2002. Mr. Termeer served as a Director of Geltex Pharmaceuticals Inc., since 1992. Mr. Termeer served as a Director of AutoImmune Inc. from 1992 to 2003. In July of 2005, Mr. Termeer was elected to Honorary Fellowship at the Royal College of Physicians. In 2001, Mr. Termeer joined the Dean's Committee for International Development of Harvard's John F. Kennedy School of Government. He is a Member of the Board of Fellows of the Harvard Medical School; the Community Affairs and Government Relations Committee of the Harvard Medical School Board of Fellows; and the Dean's Committee for International Development of Harvard's John F. Kennedy School of Government. Mr. Termeer worked to establish a variety of programs to further math and science education for the public school students of Boston. In 1994, he joined the Biomedical Science Careers Project (BSCP) and served as its Director of the BSCP since 1995. His innovative approaches have earned Genzyme the Laguna Niguel Best of Biotech award in 1991 and 1994, as well as the Laguna Niguel Hall of Fame Award in 1997. In October 1997, as part of its tenth anniversary celebration, the Biotech Meeting at Laguna Niguel honored him with the Special Recognition for an Individual Award. Mr. Termeer is also a recipient of the 1993 Laguna Niguel SWAT Team Award. He has been acknowledged by the financial publication “Wall Street Transcript“ for four consecutive years as an industry executive who advocates shareholder value. During 1990 to 1992, Mr. Termeer also received the Transcript's Gold Award. In 1992, he was named Entrepreneur of the Year by Merrill Lynch and Ernst & Young, Inc. for his achievements in establishing an innovative, successful, and growing business. In 1995, “Success Magazine“ named him Renegade of the Year; honoring business leaders whose guts and vision have paid off. In 2001, on behalf of Genzyme, he accepted the Boston History Collaborative's 2001 History Makers Award in Biotechnology, the first award of its type ever given. He is recognized as an influential supporter for people of diverse backgrounds. In 1995, Mr. Termeer was honored by the Anti-Defamation League's New England Region with the Torch of Liberty Award for his leadership in human rights

Corporate Headquarters 55 Cambridge Parkway Cambridge, Massachusetts 02142 United States Phone: 617-761-8777 Fax: 617-761-8918 Board Members Memberships Prior AutoImmune Inc. Chairman Medical Simulation Corporation Director Partners HealthCare System, Inc. Director Biotechnology Industry Organization 1983-N/A Former Chairman, Chief Executive Officer and President Genzyme Tissue Repair 1983-Present Executive Director, Member of Strategic Planning and Capital Allocation Committee and Member of Risk Oversight Committee Genzyme Corporation 1983-Present Chairman, Chief Executive Officer and President Genzyme Oncology, Inc. 1983-N/A Former Chairman, Chief Executive Officer and President Genzyme General 1983-Present Chairman, Chief Executive Officer and President Sanofi Biosurgery 1987-Present Director Abiomed Europe GmbH 1987-Present Independent Director, Member of Executive Committee, Member of Compensation Committee and Member of Audit Committee ABIOMED, Inc. 1989-N/A Former Independent Trustee, Member of Nominating Committee, Member of Governance Committee and Independent Trustee of HQL Fund H&Q Healthcare Investors 1992-N/A Former Director GelTex Pharmaceuticals, Inc. 1992-2007 Former Independent Trustee H&Q Life Sciences Investors 1993-Present Director Lotus Development Corporation 1996-N/A Former Director Diacrin, Inc. 2007-Present Chairman Federal Reserve Bank Of Boston Inc. 2011-Present Director, Member of Compensation Committee and Member of Nominating & Governance Committee AVEO Pharmaceuticals, Inc. 2011-Present Lead Director, Chairman of Compensation Committee and Member of Audit Committee Verastem, Inc. 2013-Present Director Moderna Therapeutics, Inc. Education Unknown/Other Education Erasmus University MBA 1973 Colgate W. Darden Graduate School of Business Administration Other Affiliations AutoImmune Inc. Diacrin, Inc. rEVO Biologics Lotus Development Corporation Abiomed Europe GmbH GelTex Pharmaceuticals, Inc. ABIOMED, Inc. Genzyme Tissue Repair Genzyme Corporation H&Q Life Sciences Investors H&Q Healthcare Investors Genzyme Surgical Products Genzyme General Sanofi Biosurgery Medical Simulation Corporation AVEO Pharmaceuticals, Inc. Partners HealthCare System, Inc. Federal Reserve Bank Of Boston Inc. Biotechnology Industry Organization Erasmus University Capital Royalty L.P Federal Reserve Bank of Atlanta Colgate W. Darden Graduate School of Business Administration Verastem, Inc. Moderna Therapeutics, Inc.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.